Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
22.32
-0.25 (-1.11%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Tandem Diabetes Care Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,553 | 1,490 | 2,366 | 1,929 | 2,890 | 9,563 | |
Market Cap Growth | 115.22% | -37.00% | 22.64% | -33.26% | -69.78% | 60.70% |
Enterprise Value | 1,836 | 1,625 | 2,368 | 1,849 | 2,704 | 9,284 |
Last Close Price | 22.32 | 21.98 | 36.02 | 29.58 | 44.95 | 150.52 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 614.35 |
Forward PE | - | 143.09 | 143.09 | 143.09 | 143.09 | 269.85 |
PS Ratio | 1.49 | 1.47 | 2.52 | 2.58 | 3.61 | 13.61 |
PB Ratio | 11.90 | 9.60 | 8.99 | 6.15 | 6.57 | 22.08 |
P/TBV Ratio | 11.91 | 10.39 | 9.02 | 6.21 | 6.64 | 22.42 |
P/FCF Ratio | - | - | 473.70 | - | 176.59 | 98.41 |
P/OCF Ratio | - | - | 97.65 | - | 57.27 | 85.88 |
PEG Ratio | - | 6.22 | 6.22 | 6.22 | 6.22 | 8.88 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.76 | 1.60 | 2.52 | 2.47 | 3.37 | 13.21 |
EV/EBITDA Ratio | - | - | - | - | - | 254.37 |
EV/EBIT Ratio | - | - | - | - | - | 409.83 |
EV/FCF Ratio | - | - | 474.23 | - | 165.18 | 95.53 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 5.67 | 2.90 | 1.82 | 1.34 | 0.97 | 0.73 |
Debt / EBITDA Ratio | - | - | - | - | - | 6.96 |
Debt / FCF Ratio | - | - | 95.79 | - | 25.94 | 3.24 |
Net Debt / Equity Ratio | 2.17 | 1.01 | 0.15 | -0.15 | -0.44 | -0.71 |
Net Debt / EBITDA Ratio | -11.31 | -2.59 | -0.48 | 0.38 | 4.05 | -8.47 |
Net Debt / FCF Ratio | -10.64 | -5.28 | 8.02 | 0.81 | -11.75 | -3.18 |
Asset Turnover | 1.03 | 1.10 | 0.98 | 0.75 | 0.82 | 0.87 |
Inventory Turnover | 3.30 | 3.37 | 2.93 | 2.83 | 4.32 | 4.94 |
Quick Ratio | 2.44 | 1.89 | 2.24 | 2.94 | 4.43 | 5.57 |
Current Ratio | 3.18 | 2.55 | 2.93 | 3.83 | 5.14 | 6.16 |
Return on Equity (ROE) | -48.03% | -97.89% | -33.30% | -59.08% | -21.67% | 3.89% |
Return on Assets (ROA) | -2.65% | -5.28% | -6.45% | -8.75% | -3.95% | 1.75% |
Return on Invested Capital (ROIC) | -12.10% | -25.41% | -34.83% | -54.65% | -33.27% | 18.98% |
Return on Capital Employed (ROCE) | -4.80% | -12.20% | -13.80% | -18.50% | -7.00% | 2.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -4.08% | -13.74% | -4.06% | -11.54% | -3.27% | 0.16% |
FCF Yield | -1.71% | -1.99% | 0.21% | -3.04% | 0.57% | 1.02% |
Buyback Yield / Dilution | -3.08% | -2.80% | -0.74% | -1.28% | 0.32% | -5.51% |